欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2011, Vol. 16 ›› Issue (1): 85-88.

• 药物治疗学 • 上一篇    下一篇

黄葵胶囊联合雷公藤多苷片治疗Ⅳ期糖尿病肾病的疗效观察

沈水娟, 胡作祥, 王时敏, 李青华   

  1. 浙江省绍兴市人民医院肾内科,绍兴 312000,浙江
  • 收稿日期:2010-12-06 修回日期:2011-01-06 发布日期:2020-09-16
  • 作者简介:沈水娟,女,医学硕士,副主任医师,主要从事肾内科临床工作。Tel: 13305756080 E-mail: ssj72@163.com

Clinical curative effect observation of ambrette capsule combined with tripterygium glycosides tablet on diabetic nephropathy of IV stage

SHEN Shui-juan, HU Zuo-xiang, WANG Shi-ming, LI Qing-hua   

  1. Shaoxing People's Hospital of Zhejiang Province, Shaoxing 312000, Zhejiang, China
  • Received:2010-12-06 Revised:2011-01-06 Published:2020-09-16

摘要: 目的: 观察黄葵胶囊联合雷公藤多苷片治疗糖尿病肾病的疗效。方法: 将135例糖尿病肾病Ⅳ期患者分为对照组、黄葵胶囊组和联合用药组,三组患者均给予糖尿病基础治疗。对照组:使用血管紧张素Ⅱ受体拮抗剂(ARB)控制血压及降蛋白尿治疗。黄葵胶囊组:对照组基础上加用黄葵胶囊5粒,每日3次口服。联合用药组:对照组基础上加用黄葵胶囊5粒,每日3次口服;雷公藤多苷片 1 mg/(kg·d),分3次口服。观察治疗前和治疗2、4、8、12周后 24 h 尿蛋白定量、血白蛋白、肾功能、肝功能、血脂、血常规等变化。结果: 三组治疗前 24 h 尿蛋白定量无统计学差异(P>0.05),治疗4周后黄葵胶囊组和联合用药组尿蛋白均较治疗前降低,联合用药组差异有统计学意义(P<0.01);治疗8周后黄葵胶囊组和联合用药组尿蛋白均较治疗前显著降低 (P<0.01),且联合用药组较对照组降低更显著(P<0.01)。治疗12周后黄葵胶囊组和联合用药组尿蛋白较治疗前进一步降低,且与对照组相比均有统计学差异(P<0.05 和P<0.01)。其余指标变化无统计学意义(P>0.05)。结论: 黄葵胶囊、雷公藤多苷片治疗Ⅳ期糖尿病肾病均能降低尿蛋白,从而延缓肾功能进展,但联合治疗组不仅起效快,而且效果更明显。

关键词: 黄葵, 雷公藤多苷片, 糖尿病肾病

Abstract: AIM: To observe the curative effect of ambrette capsule combined with tripterygium glycosides tablet on diabetic nephropathy.METHODS: 135 patients with diabetic nephropathy were randomly divided into combined group which was treated with traditional therapy including control blood glucose and control blood pressure with angiotensin Ⅱ receptor antagonist (ARB) and ambrette capsule 5 pieces three times a day by oral administration combined with tripterygium glycosides tablet 1 mg per day and per kilogram, ambrette group which was treated with traditional therapy and ambrette capsule 5 pieces three times a day and control group which was treated with traditional therapy .The 24 h urine protein quantitation, blood albumin, renal function, hepatic function, blood fat and blood routine were respectively detected and compared before treatment and after treatment for two, four, eight and twelve weeks.RESULTS: After 4 weeks treatment, combined group had significantly decreased the urine protein quantitation (P<0.01), but ambrette group had significantly decreased until 8 weeks treatment(P<0.01), there was no statistical significance in control group after 12 weeks treatment(P>0.05). After 12 weeks treatment, there was significant difference in the urine protein quantitation among ambrette group, combined group and control group respectively (P<0.05 and P<0.01). There was no statistical significance on the other indexes(P>0.05).CONCLUSION: Ambrette capsule or tripterygium glycosides tablet can decrease urine protein and postpone progress of renal function, but combined group had better curative effect and can shorten course of treatment.

Key words: Ambrette capsule, Tripterygium glycosides tablet, Diabetic nephropathy  ,  ,  ,  ,  

中图分类号: